The Research of Novel Electrolyzed Water Spray to Eradicate Bacteria E-coli and an Attenuated Human Flu Virus
Bacterial Growth, Novel Influenza A (H1N1)
About this trial
This is an interventional treatment trial for Bacterial Growth focused on measuring Electrolyzed water device, Hydroxyl radical, Tap water, Spray, E-coli, Human flu virus
Eligibility Criteria
Inclusion Criteria: Age 18-60 years. Male or female of any race and ethnicity. Subject agrees to comply with study requirements. Exclusion Criteria: Severely unhealthy participants. 80 years or older. Subjects with severe medical condition(s) that in the view of the investigator prohibits participation in the study. Dermatologic disease such as psoriasis or atopic dermatitis which may have inherently abnormal antimicrobial peptide levels. Subject has Netherton's syndrome or other genodermatoses that result in a defective epidermal barrier. Immunocompromised subjects, or with a history of active or malignant disease as determined by the participant's medical history. Subjects with a history of psychiatric disease or history of alcohol or drug abuse that would interfere with the ability to comply with the study protocol. Subjects with significant concurrent medical condition(s) at screening that in the view of the investigator prohibits participation in the study
Sites / Locations
- Huinuode Biotechnology Co., Ltd.
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
electrolyzed water spray group
untreated tap water group
Participants with bacteria E-coli and an attenuated human flu virus on their hands will receive one treatment with the novel electrolyzed water and complete the questionnaire.
Participants with bacteria E-coli and an attenuated human flu virus on their hands will receive one treatment with the untreated tap water and complete the questionnaire.